Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Antibe Therapeutics Inc(Pre-Merger) T.ATE


Primary Symbol: ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Post by AntibeTribeon Feb 20, 2021 12:01pm
384 Views
Post# 32618755

If you were to sit down with

If you were to sit down with
a company like PFE, BY or LLY. You wouldn't and couldn't approach them. Even with amazing PH2 results. It looks desperate and that is how you get low balled. The art of a deal is to create urgency for the perspective buying. You'd want to position yourself so that you are capable of going it alone. You'd want to establish as many partners as you can. File or refile as many patents as possible. You'd want to drive the SP up, in a calm and steady manor. I believe we have hired the right people. And that they know exactly how big pharma operates and values companies like our gem, ATE. If this was a game of poker, we are holding a royal flush. You have got to slow play a royal flush. You don't go all in before the flop. you slowly drive the pot price up with each turn, knowing all the while that you've already won.
<< Previous
Bullboard Posts
Next >>